Home > PS Ratio > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES
PS (Price/Sales) Ratio

The Current P/S Ratio of SUDARSHAN PHARMA INDUSTRIES is 1.21.

Share Price ₹35.6Aug 17,2026
Market Cap ₹888.9 Cr
Sales-TTM₹732.2 CrTTM-Consolidated Results
Price/Sales1.21xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of SUDARSHAN PHARMA INDUSTRIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SUDARSHAN PHARMA INDUSTRIES is calculated as :

Current Market Cap [ ₹888.9 Cr] as on Aug 17,2026

(/) Sales [ ₹732.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.21x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SUDARSHAN PHARMA INDUSTRIES , the investors are currently willing to pay '1.21 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SUDARSHAN PHARMA INDUSTRIES !

The chart below summarizes the trend in P/S Ratio of SUDARSHAN PHARMA INDUSTRIES over the last five years.

Historical PS (Price/Sales) ratio chart of SUDARSHAN PHARMA INDUSTRIES


PS Ratio Performance Analysis for SUDARSHAN PHARMA INDUSTRIES

- SUDARSHAN PHARMA INDUSTRIES 's latest p/e ratio is 1.21x.

- SUDARSHAN PHARMA INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.43x.

- SUDARSHAN PHARMA INDUSTRIES 's operated at median p/e ratio of 0.29x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUDARSHAN PHARMA INDUSTRIES 's p/e ratio peaked in Mar2025 at 1.46x.

- SUDARSHAN PHARMA INDUSTRIES 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does SUDARSHAN PHARMA INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SUDARSHAN PHARMA INDUSTRIES 732.21.21888.9
SUN PHARMACEUTICAL INDUSTRIES LTD59,910.57.54451,675.0
DIVIS LABORATORIES LTD11,230.020.08225,516.0
TORRENT PHARMACEUTICALS LTD15,723.011.84186,190.0
CIPLA LTD28,324.44.08115,523.0
DR REDDYS LABORATORIES LTD33,227.92.9999,493.4
MANKIND PHARMA LTD14,737.96.7399,117.0
LUPIN LTD29,966.63.45103,299.0
ZYDUS LIFESCIENCES LTD28,591.73.95112,917.0
AUROBINDO PHARMA LTD34,935.32.6893,498.9
LAURUS LABS LTD7,269.613.3797,202.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUDARSHAN PHARMA INDUSTRIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.21x
Max industry PS 20.08x
Median industry PS 4.08x
Average industry PS 7.08x



You may also like the below Video Courses